The nation of Zimbabwe has turned down a significant American health deal valued at $367m (£272m) over five years because of Washington's request for confidential data.
This rejection came to light following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesman has since stated that the United States was seeking health data for research and profit while was not willing to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued talks to find a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following concerns were raised about the security of Kenyans' health data.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
Based on reports, 16 nations in Africa have so far signed similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Effectively, our nation would supply the basic resources for medical research without any assurance that the resulting innovations would be available to our citizens should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining structures previously set up via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration could be designed in a way that honours the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that negotiations must proceed given that a large portion of the nation's HIV programmes depended on external financing.
"Where specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group commented.
The situation emphasises the ongoing tensions between receiving much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.